 |
|
|
| |
HCC RECURRENCE UNDER ALL-ORAL DAAs-BASED ANTIVIRAL THERAPY IN HCV-INFECTED
PATIENTS: DATA FROM THE NAVIGATORE WEB PLATFORM
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
1Martina Gambato, 1 Francesco Paolo Russo, 2 Sara Piovesan, 3Antonietta Romano, 1Alberto Zanetto, 4Franco Capra, 4Veronica Paon, 2Georgios
Anastassopoulos, 5Irene Franceschet , 6Antonio Carlotto, 7Silvia Storato, 8Manuela De Bona, 9Pierangelo Rovere, 10Carla Manuppelli, 11Maria
Teresa Giordani, 12Lorenzo Lomonaco, 3Paolo Angeli, 2Alfredo Alberti, 1Patrizia Burra
1 Multivisceral Transplant Unit, Gastroenterology, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy, 2Department of Molecular Medicine, University of Padova, Padova, 3Unit of Hepatic Emergencies and Liver Transplantation, Department of Surgery, University of Padova, Italy, 4Internal Medicine, Department of Biomedical and
Surgical Science, University of Verona, Verona, Italy, 5Gastroenterology, Mestre, Venice, Italy, 6Department of Infectious Diseases, Schio, Vicenza, Italy, 7Negrar Hospital, Verona, Italy, 8Gastroenterology, Feltre, Belluno, Italy, 9Department of Infectious Diseases, Legnago, Italy, 10Department of General Medicine, San Martino Hospital, Belluno, Italy, 11Department of Infectious Diseases, Vicenza, Italy, 12Gastroenterology, Bussolengo, Italy.
|
| |
|
|
|
|
|
